Work

Pharmacophore modeling and virtual screening studies for discovery of novel farnesoid X receptor (FXR) agonists

Year: 2021

Type: article

Abstract: activity by using homogeneous time resolved fluorescence (HTRF) assay and the full-length FXR reporter gene assay in HepG2 cells. Real-time PCR assay was performed to measure the expression of FXR target genes. Compounds F4 and F17 increased small heterodimer partner (SHP), in turn, suppress mRNA levels of cholesterol 7-alpha-hydroxylase (CYP7A1). The obtained compounds F4 and F17 from this study may be potential leads for developing novel FXR agonists in the treatment of metabolic diseases.

Source: RSC Advances

DOI: 10.1039/d0ra09320c

Authors: Shizhen Zhao, Wenjing Peng, Xinping Li, Le Wang, Wenbo Yin, Yan-Dong Wang, Ruifang Hou, Wei-Dong Chen

Institutions: Henan University, Shenyang Pharmaceutical University, State Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology, Inner Mongolia Medical University

Language: English

Topic: Computational Drug Discovery Methods

Subfield: Drug Discovery

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,042

Funders: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Henan University, Natural Science Foundation of Henan Province, Education Department of Henan Province, China-Japan Friendship Hospital, Fundamental Research Funds for the Central Universities

Awards: G1432344615, G2255038605, G2745451053, G2926161692, G3014216404, G393740804, G4445088411, G5205474008, G5600847293, G6234502245, G6411766591, G6742339581, G6884587249

OpenAlex ID: W3120448317

FWCI: 0.384

Cites: 29

Cited by: 7

Related to: 10